Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Hepatitis Monthly
  4. Articles

  5. Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats
  6. Scopus by Title (Ref)

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Home
Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Effect of resveratrol on key signaling pathways including SIRT1/AMPK/Smad3/TGF-β and miRNA-141 related to NAFLD in an animal model

- Yarahmadi S. , et al.

2. The efficacy of resveratrol in the treatment of liver fibrosis: a systematic review and meta-analysis of preclinical studies

- Luo D. , et al.

3. The Up-Regulation of miR-146a and miR-29b via Exosomes Protects Against Liver Fibrosis by Inhibiting the TGF-β/Smad3c Signaling Pathway

- Asl B.J. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.